Search Results 291-300 of 17435 for Mmol

1. Academics - Find a Program at Mayo Clinic College of Medicine & Science

   Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of Medicine and Science.

2. Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma - Mayo Clinic

   Fasting serum cholesterol ≤ 300 mg/dL OR ≤ 7.75 mmol/L AND fasting triglycerides ≤ 2.5 x ULN (NOTE: Lipid lowering medication is allowed); ECOG ...

3. Pazopanib Hydrochloride in Treating Patients with Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma - Mayo Clinic

   Hemoglobin ≥ 9 g/dL (5.6 mmol/L); transfusions not permitted ≤ 7 days of registration; Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) ...

4. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

   Hemoglobin > 9.0 g/dL or ≥ 5.6 mmol/L without transfusion or (EPO) erythropoietin dependency (within 7 days of assessment);; Serum total bilirubin ≤ 1.5 X ...

5. Chemoembolization Clinical Trials - Mayo Clinic Research

   The purpose of this study is to compare stereotactic body radiation therapy (SBRT) to trans-arterial chemoembolization (TACE) as a bridging strategy for ...

6. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

7. Clinical Trials - The PEERLESS II Study

   Elevated venous lactate ≥2 mmol/L * Elevated, meaning at or above the upper limit of normal, per local standards for the assay used c. Respiratory: i. O2 ...

8. Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score - Mayo Clinic

   Serum potassium ≥ 3.5 mmol/L prior to Step 2 randomization. Exclusion Criteria: PRIOR TO STEP 1 REGISTRATION. Definitive radiologic evidence of metastatic ...

9. Cancer Treatment! Clinical Trials - Mayo Clinic Research

   The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-C137 in ...

10. Novel MOG assay aids diagnosis of demyelinating diseases - Mayo Clinic

    Mayo Clinic has developed the first test available in the United States to identify the myelin oligodendrocyte glycoprotein (MOG) antibody in patients' ...